Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome?
BMJ
.
2017 Aug 16:358:j3694.
doi: 10.1136/bmj.j3694.
Authors
Tessa Copp
1
2
,
Jesse Jansen
3
2
,
Jenny Doust
4
5
,
Ben Wj Mol
6
7
,
Anuja Dokras
8
,
Kirsten McCaffery
1
2
Affiliations
1
Wiser Healthcare, Sydney School of Public Health, University of Sydney, NSW 2006, Australia.
2
Centre for Medical Psychology and Evidence-Based Decision-Making (CeMPED), University of Sydney, NSW 2006, Australia.
3
Wiser Healthcare, Sydney School of Public Health, University of Sydney, NSW 2006, Australia jesse.jansen@sydney.edu.au.
4
Wiser Healthcare, Bond University, QLD 4229, Australia.
5
Centre for Research in Evidence-Based Practice, Bond University, QLD 4229, Australia.
6
Robinson Research Institute, School of Paediatrics and Reproductive Health, University of Adelaide, SA 5005, Australia.
7
The South Australian Health and Medical Research Institute, Adelaide, Australia.
8
Penn PCOS Centre, Department of Obstetrics and Gynaecology, University of Pennsylvania, Philadelphia, US.
PMID:
28814559
DOI:
10.1136/bmj.j3694
No abstract available
MeSH terms
Adolescent
Adult
Age Factors
Female
Humans
Medical Overuse
Polycystic Ovary Syndrome / diagnosis*
Polycystic Ovary Syndrome / epidemiology
Polycystic Ovary Syndrome / pathology
Prevalence
Risk Factors
Young Adult